{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:48Z","timestamp":1761823848841},"reference-count":50,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Gallstones, particularly cholesterol gallstones, are common in Western populations and may cause symptoms such as biliary colic or complications such as acute cholecystitis or gallstone pancreatitis. Recent studies have allowed for a better understanding of the risk of symptoms or complications in patients with gallstones. In addition, newer data suggest an association of gallstones with overall mortality, cardiovascular disease, gastrointestinal cancers, and non-alcoholic fatty liver disease. Knowledge of appropriate indications and timing of cholecystectomy, particularly for mild biliary pancreatitis, has gradually accumulated. Lastly, there are exciting possibilities for novel agents to treat or prevent cholesterol stone disease. This review covers new advances in our understanding of the natural history, clinical associations, and management of gallstone disease.<\/ns4:p>","DOI":"10.12688\/f1000research.8874.1","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:00:06Z","timestamp":1469523606000},"page":"1817","update-policy":"http:\/\/dx.doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Gallstones: new insights into an old story"],"prefix":"10.12688","volume":"5","author":[{"given":"Evan","family":"Tiderington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sum P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia W.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"230-9","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease.","volume":"368","author":"P Portincasa","year":"2006","journal-title":"Lancet."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"632-9","DOI":"10.1016\/S0016-5085(99)70456-7","article-title":"Prevalence and ethnic differences in gallbladder disease in the United States.","volume":"117","author":"J Everhart","year":"1999","journal-title":"Gastroenterology."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"937-46","DOI":"10.1016\/S0016-5085(98)70266-5","article-title":"Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris.","volume":"115","author":"J Miquel","year":"1998","journal-title":"Gastroenterology."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1358-64","DOI":"10.1056\/NEJM197012172832502","article-title":"Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography.","volume":"283","author":"R Sampliner","year":"1970","journal-title":"N Engl J Med."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1319-26","DOI":"10.1158\/1055-9965.EPI-15-0199","article-title":"Gallbladder Cancer Incidence and Mortality, United States 1999-2011.","volume":"24","author":"S Henley","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"2446-54","DOI":"10.1002\/ijc.25421","article-title":"Gallbladder cancer: incidence and survival in a high-risk area of Chile.","volume":"127","author":"E Bertran","year":"2010","journal-title":"Int J Cancer."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"245-64","DOI":"10.1016\/j.gtc.2010.02.005","article-title":"Targets for current pharmacologic therapy in cholesterol gallstone disease.","volume":"39","author":"A Di Ciaula","year":"2010","journal-title":"Gastroenterol Clin North Am."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"185-207","DOI":"10.1016\/j.gtc.2010.02.007","article-title":"Lith genes and genetic analysis of cholesterol gallstone formation.","volume":"39","author":"H Wang","year":"2010","journal-title":"Gastroenterol Clin North Am."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones.","volume":"2","author":"F Lammert","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"798-800","DOI":"10.1056\/NEJM198209233071305","article-title":"The natural history of silent gallstones: the innocent gallstone is not a myth.","volume":"307","author":"W Gracie","year":"1982","journal-title":"N Engl J Med."},{"key":"ref-11","doi-asserted-by":"crossref","first-page":"59-63","DOI":"10.1097\/00000658-198507000-00009","article-title":"The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients.","volume":"202","author":"C McSherry","year":"1985","journal-title":"Ann Surg."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"655-60","DOI":"10.1002\/hep.1840210309","article-title":"The natural history of gallstones: the GREPCO experience. The GREPCO Group.","volume":"21","author":"A Attili","year":"1995","journal-title":"Hepatology."},{"key":"ref-13","first-page":"249-54","article-title":"Ten-year incidence and natural history of gallstone disease in a rural population of women in central Italy. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).","volume":"29","author":"F Angelico","year":"1997","journal-title":"Ital J Gastroenterol Hepatol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"719-24","DOI":"10.1111\/j.1440-1746.2009.06146.x","article-title":"Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study.","volume":"25","author":"D Festi","year":"2010","journal-title":"J Gastroenterol Hepatol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"734-8","DOI":"10.1002\/bjs.4547","article-title":"Development of symptoms and complications in individuals with asymptomatic gallstones.","volume":"91","author":"I Halldestam","year":"2004","journal-title":"Br J Surg."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"156-167.e1","DOI":"10.1053\/j.gastro.2015.09.002","article-title":"A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study.","volume":"150","author":"D Shabanzadeh","year":"2016","journal-title":"Gastroenterology."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"349-53","DOI":"10.1007\/BF01296286","article-title":"Radiologic appearance of gallstones and its relationship with biliary symptoms and awareness of having gallstones. Observations during epidemiological studies. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).","volume":"32","year":"1987","journal-title":"Dig Dis Sci."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"856-60","DOI":"10.1002\/hep.1840090611","article-title":"Abdominal symptoms and gallstone disease: an epidemiological investigation.","volume":"9","author":"T J\u00f8rgensen","year":"1989","journal-title":"Hepatology."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"2540-50","DOI":"10.1111\/j.1572-0241.2005.00317.x","article-title":"Small gallstones are associated with increased risk of acute pancreatitis: potential benefits of prophylactic cholecystectomy?","volume":"100","author":"N Venneman","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"508-16","DOI":"10.1053\/j.gastro.2010.10.060","article-title":"Gallstone disease is associated with increased mortality in the United States.","volume":"140","author":"C Ruhl","year":"2011","journal-title":"Gastroenterology."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"2232-7","DOI":"10.1161\/ATVBAHA.115.306043","article-title":"Gallstone Disease and the Risk of Ischemic Heart Disease.","volume":"35","author":"J Lv","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"326-34","DOI":"10.1177\/2047487313512218","article-title":"Presence of gallstones and the risk of cardiovascular diseases: The EPIC-Germany cohort study.","volume":"22","author":"J Wirth","year":"2015","journal-title":"Eur J Prev Cardiol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"731-9","DOI":"10.1093\/aje\/kwt322","article-title":"Gallstones, cholecystectomy, and risk of digestive system cancers.","volume":"179","author":"L Nogueira","year":"2014","journal-title":"Am J Epidemiol."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1813-20","DOI":"10.1111\/j.1572-0241.2005.41610.x","article-title":"Cholecystectomy and the risk of colorectal cancer.","volume":"100","author":"T Shao","year":"2005","journal-title":"Am J Gastroenterol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"923-31","DOI":"10.1007\/s00535-013-0846-6","article-title":"Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort study.","volume":"49","author":"Y Chen","year":"2014","journal-title":"J Gastroenterol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"553-64","DOI":"10.3109\/00365521.2012.660538","article-title":"Gallstone disease is associated with rectal cancer: a meta-analysis.","volume":"47","author":"C Chiong","year":"2012","journal-title":"Scand J Gastroenterol."},{"key":"ref-27","first-page":"1994-9","article-title":"Gallstones, cholecystectomy, and colorectal cancer.","volume":"88","author":"M McFarlane","year":"1993","journal-title":"Am J Gastroenterol."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"79-83","DOI":"10.1038\/sj.bjc.6600661","article-title":"Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas.","volume":"88","author":"E Schernhammer","year":"2003","journal-title":"Br J Cancer."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"882-9","DOI":"10.1007\/s00535-013-0832-z","article-title":"Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.","volume":"49","author":"Y Takahashi","year":"2014","journal-title":"J Gastroenterol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"237-43","DOI":"10.1016\/S1590-8658(03)00060-4","article-title":"Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls.","volume":"35","author":"W Chen","year":"2003","journal-title":"Dig Liver Dis."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"952-8","DOI":"10.1038\/ajg.2013.70","article-title":"Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population.","volume":"108","author":"C Ruhl","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"197-203","DOI":"10.3109\/00365521.2011.643481","article-title":"Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.","volume":"47","author":"T Koller","year":"2012","journal-title":"Scand J Gastroenterol."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"708-14","DOI":"10.1136\/gut.2005.076133","article-title":"Central adiposity, regional fat distribution, and the risk of cholecystectomy in women.","volume":"55","author":"C Tsai","year":"2006","journal-title":"Gut."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"299-305","DOI":"10.1016\/j.jhep.2006.01.026","article-title":"Gallbladder disease is associated with insulin resistance in a high risk Hispanic population.","volume":"45","author":"F Nervi","year":"2006","journal-title":"J Hepatol."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"368-73","DOI":"10.1016\/j.jdiacomp.2015.11.012","article-title":"Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies.","volume":"30","author":"D Aune","year":"2016","journal-title":"J Diabetes Complicat."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"299-303","DOI":"10.1002\/hep.510310206","article-title":"Association of diabetes, serum insulin, and C-peptide with gallbladder disease.","volume":"31","author":"C Ruhl","year":"2000","journal-title":"Hepatology."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"159-65","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance.","volume":"21","author":"S Fang","year":"2015","journal-title":"Nat Med."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"523-32","DOI":"10.1517\/17425255.2014.999664","article-title":"Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility.","volume":"11","author":"I Koutsounas","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"519-31","DOI":"10.5551\/jat.19778","article-title":"Liver X receptor: a cardinal target for atherosclerosis and beyond.","volume":"21","author":"M Parikh","year":"2014","journal-title":"J Atheroscler Thromb."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"1352-8","DOI":"10.1038\/nm1138","article-title":"Prevention of cholesterol gallstone disease by FXR agonists in a mouse model.","volume":"10","author":"A Moschetta","year":"2004","journal-title":"Nat Med."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"640-4","DOI":"10.1038\/sj.bjc.6690101","article-title":"Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.","volume":"79","author":"W Chow","year":"1999","journal-title":"Br J Cancer."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"1011-5","DOI":"10.1038\/bjc.2011.607","article-title":"Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma.","volume":"106","author":"H Nordenstedt","year":"2012","journal-title":"Br J Cancer."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"92-8","DOI":"10.1016\/j.annepidem.2009.11.010","article-title":"Past medical history and pancreatic cancer risk: Results from a multicenter case-control study.","volume":"20","author":"P Maisonneuve","year":"2010","journal-title":"Ann Epidemiol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"CD007196","DOI":"10.1002\/14651858.CD007196.pub3","article-title":"Early versus delayed laparoscopic cholecystectomy for uncomplicated biliary colic.","author":"K Gurusamy","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"CD010326","DOI":"10.1002\/14651858.CD010326.pub2","article-title":"Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitis.","author":"K Gurusamy","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"CD005440","DOI":"10.1002\/14651858.CD005440.pub2","article-title":"Early versus delayed laparoscopic cholecystectomy for acute cholecystitis.","author":"K Gurusamy","year":"2006","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"CD007196","DOI":"10.1002\/14651858.CD007196.pub2","article-title":"Early versus delayed laparoscopic cholecystectomy for biliary colic.","author":"K Gurusamy","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"1261-8","DOI":"10.1016\/S0140-6736(15)00274-3","article-title":"Same-admission versus interval cholecystectomy for mild gallstone pancreatitis (PONCHO): a multicentre randomised controlled trial.","volume":"386","author":"D da Costa","year":"2015","journal-title":"Lancet."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"1159-68","DOI":"10.1111\/eci.12350","article-title":"Ezetimibe prevents the formation of oestrogen-induced cholesterol gallstones in mice.","volume":"44","author":"O de Bari","year":"2014","journal-title":"Eur J Clin Invest."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"2101-10","DOI":"10.1053\/j.gastro.2008.03.011","article-title":"Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.","volume":"134","author":"H Wang","year":"2008","journal-title":"Gastroenterology."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T11:36:11Z","timestamp":1553254571000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":50,"URL":"https:\/\/doi.org\/10.12688\/f1000research.8874.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.9549.r15222","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.9549.r15224","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.9549.r15225","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.9549.r15222, William Tao-Hsin Tung, Department of Medical Research and Education, Cheng-Hsin General Hospital, Taipei, Taiwan, 26 Jul 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1#referee-response-15222","order":0,"name":"referee-response-15222","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.9549.r15224, Richard Kozarek, Gastroenterology, Virginia Mason Medical Center, Seattle, WA, USA, 26 Jul 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1#referee-response-15224","order":1,"name":"referee-response-15224","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.9549.r15225, Gabriel Sandblom, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska University Hospital, Stockholm, Sweden, 26 Jul 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-1817\/v1#referee-response-15225","order":2,"name":"referee-response-15225","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}